Pongracz K, Pathak D N, Nakamura T, Burlingame A L, Bodell W J
Brain Tumor Research Center, School of Medicine, University of California, San Francisco 94143, USA.
Cancer Res. 1995 Jul 15;55(14):3012-5.
(Z)-1,2-Diphenyl-1-(4-hydroxyphenyl)but-1-ene (metabolite E) has been detected in the plasma of patients treated with tamoxifen. We therefore investigated whether the cis/trans isomers of metabolite E can be activated to form DNA adducts detected by 32P postlabeling. Microsomal activation of metabolite E produced two major (a and b) and up to six minor DNA adducts. Activation with horseradish peroxidase or silver(I)oxide produced the same adducts (a and b). Microsomal activation of tamoxifen produced one major (no. 6) and several minor DNA adducts. Rechromatography showed that adducts a and b formed by enzymatic and chemical activation of metabolite E were the same as adducts 9 and 4 produced by microsomal activation of tamoxifen. These results demonstrate that activation of metabolite E can lead to DNA adduct formation.
在用他莫昔芬治疗的患者血浆中已检测到(Z)-1,2-二苯基-1-(4-羟基苯基)丁-1-烯(代谢物E)。因此,我们研究了代谢物E的顺式/反式异构体是否可被激活以形成通过32P后标记检测到的DNA加合物。代谢物E的微粒体激活产生了两个主要的(a和b)以及多达六个次要的DNA加合物。用辣根过氧化物酶或氧化银(I)激活产生了相同的加合物(a和b)。他莫昔芬的微粒体激活产生了一个主要的(6号)和几个次要的DNA加合物。再色谱分析表明,代谢物E经酶促和化学激活形成的加合物a和b与他莫昔芬微粒体激活产生的加合物9和4相同。这些结果表明,代谢物E的激活可导致DNA加合物的形成。